Abstract
Purpose
Patient-reported outcomes are important in the surgical decision-making process for low-risk, differentiated thyroid cancer. Current study aimed to assess patient-reported outcomes in thyroid cancer survivors comparing total thyroidectomy (TT) and lobectomy (LT) using the Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship (PROFILES) registry.
Methods
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) scales, illness perception questions, Beliefs about Medicines Questionnaire (BMQ) scales and questions about thyroid surgery–related medication use were compared between thyroid cancer patients who underwent TT versus LT using descriptive analyses.
Results
In total, 58 thyroid cancer patients who underwent TT or LT were included in this study. None of the EORTC QLQ-C30 scales or questions regarding illness perception were significantly different between the surgical groups. Patients in the TT group had significantly higher belief in the necessity of their medication (21.0 vs 15.4; p = 0.003) and greater concerns about taking their medicines (14.7 vs 11.1; p = 0.008) versus patients in the LT group.
Conclusion
Concerns about post-surgical medication use specifically in the TT group may indicate that clinicians should consider LT in patients with low-risk, differentiated thyroid cancer when LT and TT are viable surgical options. Clinicians should be aware of the impact of post-surgical medication use in particular following TT and use this knowledge to align goals of treatment with the extent of surgery, allowing for a better-informed decision-making process.
Similar content being viewed by others
Availability of data and materials
The data used is freely available in a de-identified manner for research purposes in the PROFILES registry, a Dutch database for the study of the physical and psychosocial impact of cancer and its treatment (www.profilesregistry.nl).
Code availability
All statistical analyses were performed using SAS software, v9.4 (SAS Institute, Cary NC).
References
Wiltshire JJ, Drake TM, Uttley L, Basubramanian SP (2016) Systematic review of trends in the incidence rates of thyroid cancer. Thyroid 26(11):1541–1552
Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18):2164–2167
Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140(4):317–322
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133
Wang TS, Goffredo P, Sosa JA, Roman SA (2014) Papillary thyroid microcarcinoma: an over-treated malignancy? World J Surg 38(9):2297–2303
Van Gerwen M, Alsen M, Lee E, Sinclair C, Genden E, Taioli E (2021) Recurrence-free survival after total thyroidectomy and lobectomy in patients with papillary thyroid microcarcinoma. J Endocrinol Invest 44(4):725–734
Gartland RM, Lubitz CC (2018) Impact of extent of surgery on tumor recurrence and survival for papillary thyroid cancer patients. Ann Surg Oncol 25(9):2520–2525
Welch HG, Doherty GM (2018) Saving thyroids - overtreatment of small papillary cancers. N Engl J Med 379(4):310–312
Zerey M, Prabhu AS, Newcomb WL, Lincourt AE, Kercher KW, Heniford BT (2009) Short-term outcomes after unilateral versus complete thyroidectomy for malignancy: a national perspective. Am Surg 75(1):20–24
Grani G, Ramundo V, Verrienti A, Sponziello M, Durante C (2018) Thyroid hormone therapy in differentiated cancer. Endocrine 66(1):43–50
Mendelsohn AH, Elashoff DA, Abemayor E, St John MA (2010) Surgery for papillary thyroid carcinoma: is lobectomy enough? Arch Otolaryngol Head Neck Surg 136(11):1055–1061
Barney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD (2011) Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck 33(5):645–649
Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, ReedSD et al (2014) Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg 260(4):601–605 (discussion 5–7)
Hedman C, Djarv T, Strang P, Lundgren CI (2016) Determinants of long-term quality of life in patients with differentiated thyroid carcinoma - a population-based cohort study in Sweden. Acta Oncol 55(3):365–369
Hoftijzer HC, Heemstra KA, Corssmit EP, van der Klaauw AA, Romijn JA, Smit JWA (2008) Quality of life in cured patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 93(1):200–203
Mols F, Schoormans D, Smit JWA, Netea-Maier RT, van der Links TP, GRaaf, W.T.A., et al (2018) Age-related differences in health-related quality of life among thyroid cancer survivors compared with a normative sample: results from the PROFILES Registry. Head Neck 40(10):2235–2245
Husson O, Haak HR, Buffart LM, Nieuwlaat W-A, Oranje WA, Mols F et al (2013) Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry. Acta Oncol 52(2):249–258
Pelttari H, Sintonen H, Schalin-Jäntti C, Välimäki MJ (2009) Health-related quality of life in long-term follow-up of patients with cured TNM stage I or II differentiated thyroid carcinoma. Clin Endocrinol 70(3):493–497
van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK et al (2011) The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer 47(14):2188–2194
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376
Broadbent E, Petrie KJ, Main J, Weinman J (2006) The brief illness perception questionnaire. J Psychosom Res 60(6):631–637
Horne R, Weinman J, Hankins M (1999) The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 14(1):1–24
Kandil E, Krishnan B, Noureldine SI, Yao L, Tufano RP (2013) Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications. ORL J Otorhinolaryngol Relat Spec 75(1):6–17
Schmitz-Winnenthal FH, Schimmack S, Lawrence B, Maier U, Heidmann M, Buchler MW et al (2011) Quality of life is not influenced by the extent of surgery in patients with benign goiter. Langenbecks Arch Surg 396(8):1157
Bongers PJ, Greenberg CA, Hsiao R, Vermeer M, Vriens MR, Lutke Holzik MF et al (2020) Differences in long-term quality of life between hemithyroidectomy and total thyroidectomy in patients treated for low-risk differentiated thyroid carcinoma. Surgery 167(1):94–101
Nickel B, Tan T, Cvejic E, Baade P, McLeod DSA, Pandey N et al (2019) Health-related quality of life after diagnosis and treatment of differentiated thyroid cancer and association with type of surgical treatment. JAMA Otolaryngol Head Neck Surg 145(3):231–238
Acknowledgements
This paper draws on data of the Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship (Profiles) Registry.
Author information
Authors and Affiliations
Contributions
Maaike van Gerwen, Floortje Mols, Rebecca Schwartz, and Eric Genden contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Maaike van Gerwen, Naomi Alpert, and Rebecca Schwartz. The first draft of the manuscript was written by Maaike van Gerwen and Peter Cooke, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
The certified Medical Ethics Committee of the Maxima Medical Centre, the Netherlands, approved initial data collection for the PROFILES registry. As the PROFILES data is currently freely available in a de-identified manner for research purposes (www.profilesregistry.nl), the Icahn School of Medicine at Mount Sinai’s Institutional Review Board considered the current study exempt.
Consent to participate
Informed consent was obtained from all individual participants included in the original study.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
van Gerwen, M., Cooke, P.V., Alpert, N. et al. Patient-reported outcomes following total thyroidectomy and lobectomy in thyroid cancer survivors: an analysis of the PROFILES Registry data. Support Care Cancer 30, 687–693 (2022). https://doi.org/10.1007/s00520-021-06355-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-021-06355-x